Estados financieros detallados de Atea Pharmaceuticals, Inc. (AVIR): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $5.15, AVIR presenta beneficios negativos (P/E no significativo) y un ROE del -64.25%. La capitalización bursátil es de $412M.
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | $48.6M | $351.4M | 0 | 0 | 0 | 0 |
| Coste de Ventas | $17000 | $17000 | $38.0M | $167.2M | $62.4M | $70.1M | $83.4M | 0 |
| Beneficio Bruto | -$17000 | -$17000 | $10.6M | $184.2M | -$62.4M | -$70.1M | -$83.4M | 0 |
| I+D | $6.7M | $10.2M | $38.0M | $167.2M | $88.8M | $132.8M | $145.4M | $148.0M |
| Generales y Administrativos | $2.8M | $4.4M | $21.6M | $45.8M | $48.7M | $49.9M | $48.8M | $32.9M |
| Gastos Operativos | $9.5M | $14.6M | $21.6M | $45.8M | $68.3M | $94.1M | $109.6M | $180.9M |
| Beneficio Operativo | -$9.5M | -$14.6M | -$11.0M | $138.4M | -$130.7M | -$164.2M | -$192.9M | -$180.9M |
| EBITDA | -$9.5M | -$14.6M | -$11.0M | $138.6M | -$110.8M | -$119.6M | -$131.8M | -$164.1M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | $11.2M | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$9.1M | -$14.0M | -$10.9M | $138.6M | -$119.5M | -$134.9M | -$167.5M | -$164.5M |
| Impuestos | 0 | 0 | 0 | $17.4M | -$3.6M | $1.0M | $925000 | -$6.2M |
| Beneficio Neto | -$9.1M | -$13.5M | -$10.9M | $121.2M | -$115.9M | -$136.0M | -$168.4M | -$158.3M |
| BPA | $-0.90 | $-0.16 | $-0.13 | $1.46 | $-1.39 | $-1.63 | $-2.00 | $-1.94 |
| BPA Diluido | $-0.90 | $-0.16 | $-0.13 | $1.37 | $-1.39 | $-1.63 | $-2.00 | $-1.94 |
| Acciones en Circulación (Diluidas) | $10.1M | $82.6M | $82.4M | $88.2M | $83.2M | $83.4M | $84.3M | $81.5M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$38.2M | 0 | -$104000 | 0 |
| Beneficio Operativo | -$45.6M | -$54.9M | -$48.0M | -$35.1M |
| EBITDA | -$41.7M | -$51.5M | -$45.3M | -$32.7M |
| Beneficio Neto | -$42.0M | -$44.9M | -$45.4M | -$32.9M |
| BPA | $-0.53 | $-0.57 | $-0.57 | $-0.41 |
| BPA Diluido | $-0.53 | $-0.57 | $-0.57 | $-0.41 |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $34.5M | $21.7M | $850.1M | $764.4M | $646.7M | $143.8M | $64.7M | $95.7M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | $434.3M | $390.0M | $206.1M |
| Cuentas por Cobrar | 0 | 0 | $5.8M | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $34.7M | $21.9M | $863.5M | $772.4M | $660.9M | $590.5M | $462.4M | $311.0M |
| Inmovilizado Material | $56000 | $41000 | $48000 | $184000 | $4.1M | $3.1M | $2.1M | $1.1M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $34.9M | $22.1M | $863.6M | $772.9M | $666.7M | $595.0M | $464.7M | $315.2M |
| Cuentas por Pagar | $391000 | $548000 | $60000 | $4.5M | $2.6M | $4.3M | $4.5M | $12.9M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $843000 |
| Pasivos Corrientes | $1.8M | $2.4M | $315.8M | $56.9M | $18.5M | $32.4M | $18.6M | $39.8M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $71.0M | $2.5M | $315.8M | $62.8M | $26.1M | $39.8M | $25.8M | $39.8M |
| Reservas | -$40.2M | -$54.2M | -$65.2M | $56.0M | -$59.9M | -$195.8M | -$364.2M | -$522.6M |
| Patrimonio Neto | -$36.2M | $19.5M | $547.8M | $710.1M | $640.6M | $555.2M | $438.9M | $275.4M |
| Deuda Total | 0 | 0 | 0 | $197000 | $3.1M | $2.4M | $1.6M | $843000 |
| Deuda Neta | -$34.5M | -$21.7M | -$850.1M | -$764.2M | -$643.6M | -$575.7M | -$453.1M | -$301.0M |
| Capital Circulante | $32.9M | $19.5M | $547.7M | $715.5M | $642.4M | $558.1M | $443.8M | $271.2M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $77.3M | $95.7M | $79.3M | $76.5M |
| Activos Totales | $343.0M | $315.2M | $267.1M | $232.3M |
| Pasivos Totales | $27.2M | $39.8M | $33.4M | $28.1M |
| Patrimonio Neto | $315.8M | $275.4M | $233.7M | $204.2M |
| Deuda Total | $1.0M | $843000 | $634000 | $424000 |
Flujo de Caja (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$9.1M | -$14.0M | -$10.9M | $121.2M | -$115.9M | -$136.0M | -$168.4M | -$158.3M |
| Amortizaciones | $17000 | $17000 | $19000 | $29000 | $260000 | $416000 | $416000 | $416000 |
| Compensación en Acciones | $414000 | $624000 | $7.5M | $39.6M | $46.7M | $49.4M | $51.8M | $20.7M |
| Cambio en Capital Circulante | $725000 | $579000 | $300.2M | -$247.8M | -$46.6M | $16.2M | -$7.5M | $16.5M |
| Flujo de Caja Operativo | -$7.9M | -$12.8M | $296.7M | -$87.0M | -$121.0M | -$85.4M | -$135.5M | -$132.0M |
| Inversiones (CapEx) | -$12000 | -$2000 | -$26000 | -$4000 | -$1.9M | 0 | 0 | 0 |
| Adquisiciones | 0 | 0 | 0 | 0 | $453467 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -$25.5M |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$7.9M | -$12.8M | $296.7M | -$87.0M | -$122.9M | -$85.4M | -$135.5M | -$132.0M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$40.4M | -$28.2M | -$46.4M | -$37.1M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$40.4M | -$28.2M | -$46.4M | -$37.1M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $4.5M | $4.6M | $3.7M | $3.4M |
Crecimiento y Márgenes (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | | +622.5% | -100.0% | | | |
| Crecimiento Beneficio Neto (anual) | | -48.5% | +18.7% | +1207.1% | -195.6% | -17.3% | -23.9% | +6.0% |
| Crecimiento BPA (anual) | | +82.2% | +18.8% | +1223.1% | -195.2% | -17.3% | -22.7% | +3.0% |
| Cambio en Acciones (anual) | | +718.7% | -0.2% | +7.1% | -5.7% | +0.2% | +1.0% | -3.3% |
| Crecimiento FCF (anual) | | -61.8% | +2415.1% | -129.3% | -41.3% | +30.5% | -58.7% | +2.6% |
| Margen Bruto | | | 21.8% | 52.4% | | | | |
| Margen Operativo | | | -22.7% | 39.4% | | | | |
| Margen EBITDA | | | -22.6% | 39.5% | | | | |
| Margen Neto | | | -22.5% | 34.5% | | | | |
| Margen FCF | | | 610.1% | -24.8% | | | | |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | 12.6% | 3.0% | -0.8% | -0.6% | 3.7% |
Datos por Acción (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.78 | $-0.16 | $3.60 | $-0.99 | $-1.48 | $-1.02 | $-1.61 | $-1.62 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $10.1M | $82.6M | $82.4M | $82.8M | $83.2M | $83.4M | $84.3M | $81.5M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -64.25% |
| Rentabilidad sobre capital invertido | -86.35% |
| Rentabilidad sobre activos | -71.16% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 8.13 |
Ratios Clave (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -33.71 | -189.62 | -321.38 | 6.12 | -3.46 | -1.87 | -1.68 | -1.84 |
| P/VC | -8.47 | 128.26 | 6.29 | 1.04 | 0.63 | 0.46 | 0.64 | 1.06 |
| P/V | 0.00 | 0.00 | 70.82 | 2.11 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 21.8% | 52.4% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | -22.7% | 39.4% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | -22.5% | 34.5% | 0.0% | 0.0% | 0.0% | 0.0% |